
CAS 2138811-33-1
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
Amlodipine Related Compound A (3-Ethyl 5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylate] fumarate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C20H23ClN2O5·C4H4O4Color and Shape:White PowderMolecular weight:522.93Dehydro Amlodipine (fumarate)
CAS:<p>Dehydro amlodipine is an impurity in amlodipine, forming under storage, oxidative, acidic, photo, or electrochemical conditions.</p>Formula:C24H27ClN2O9Color and Shape:SolidMolecular weight:522.943-Ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate fumarate
CAS:3-Ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate fumaratePurity:97%Molecular weight:522.94g/molAmlodipine EP Impurity D Besylate (Amlodipine USP Related Compound A Besylate, Dehydro Amlodipine Besylate)
CAS:Formula:C20H23ClN2O5·C6H6O3SColor and Shape:Pale Yellow Semi-SolidMolecular weight:406.86 158.173-Ethyl 5-Methyl 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate Fumarate
CAS:Controlled ProductFormula:C20H23ClN2O5·C4H4O4Color and Shape:NeatMolecular weight:522.93Dehydro Amlodipine Fumarate
CAS:<p>Applications This is the salt form of 3-Ethyl 5-methyl 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate, an impurity of levamlodipine besylate tablets.<br>References Li, Jie, et al.: Yaowu Fenxi Zazhi, 35(11), 1999-2005 (2015)<br></p>Formula:C20H23ClN2O5·C4H4O4Color and Shape:White To Off-WhiteMolecular weight:522.93Amlodipine EP Impurity D (Fumarate salt)
CAS:Formula:C20H23ClN2O5C4H4O4Molecular weight:406.9 : 116.13-Ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl) -6-methylpyridine-3,5-dicarboxylate 2- butenedioate
CAS:<p>3-Ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl) -6-methylpyridine-3,5-dicarboxylate 2- butenedioate is a synthetic compound that has been developed for the treatment of bacterial infections. This drug product is metabolized by hydrolysis to form 3,5-dimethyl 2-(2-(2-(2-(2-(2-(2-(hydroxymethyl)amino)ethoxy) ethoxy)ethoxy)ethoxy)ethoxy)-4,6-dimethylpyridine. The analytical standards for this drug are 3,5-dimethyl 2-(2-(2-(2-(2 (hydroxymethyl)amino)ethoxy)ethoxy)ethoxy)-4,6-dimethylpyridine; 3,5-, 6-, and 8-, 10-, 12-, 14-, 16-, 18-,</p>Formula:C20H23ClN2O5•C4H4O4Purity:Min. 95%Color and Shape:PowderMolecular weight:522.93 g/mol









